I am not disagreeing about Hong Kong as a gateway to China. The two are now very intertwined and it would be a matter of time before CardioCel osmosized into China proper. A lot of Chinese surgeons now do part of their training in US/Australia centres. I would not be the least bit surprised if some surgeons from major centres in China now enquiring about CardioCel. Maybe one for Julian ?
Ann: Admedus expands CardioCel market, page-100
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.48 |
Change
-0.020(0.17%) |
Mkt cap ! $242.6M | |||
| Open | High | Low | Value | Volume |
| $11.50 | $11.50 | $10.91 | $152.9K | 13.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 257 | $11.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.50 | 4416 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |